title: Primary breast cancer: mammographic changes after neoadjuvant chemotherapy, with pathologic correlation.
abstract: OBJECTIVE
  To correlate changes depicted at mammography during neo-adjuvant chemotherapy for operable breast carcinoma with subsequent pathologic status.
  
  
  METHODS
  Patients (n = 107) underwent mammography before and after neoadjuvant chemotherapy, prior to surgery. Four retrospectively determined grades of response at mammography included complete, mammographic (decreased size and/or density), stable disease, or progressive disease.
  
  
  RESULTS
  In 95 fully assessable patients, grade of response to chemotherapy was complete in eight (9%), mammographic in 78 (82%), stable disease in seven (7%), and progressive disease in two (2%). Before and after treatment, respectively, 64 (67%) and 20 (21%) masses were greater than 2 cm in bidimensional diameter. Response was not complete in any of the 44 (46%) cases of microcalcifications. At histologic examination after surgery in 95 fully assessable patients, five of eight patients with complete response were found to have residual tumor (three with an invasive component); eight were found to have no residual tumor (response in three was complete; in four, mammographic; and in one, stable disease).
  
  
  CONCLUSIONS
  Whereas mammograms in most patients showed some response to chemotherapy, prediction of pathologic outcome was not possible.
authors.affiliation: Department of Diagnostic Radiology, Royal Marsden Hospital, Sutton, Surrey, England.
authors.forename: S J
authors.initials: SJ
authors.lastname: Vinnicombe
authors.forename: A D
authors.initials: AD
authors.lastname: MacVicar
authors.forename: R L
authors.initials: RL
authors.lastname: Guy
authors.forename: J P
authors.initials: JP
authors.lastname: Sloane
authors.forename: T J
authors.initials: TJ
authors.lastname: Powles
authors.forename: G
authors.initials: G
authors.lastname: Knee
authors.forename: J E
authors.initials: JE
authors.lastname: Husband
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001940:Breast / Q000473:pathology*; D001943:Breast Neoplasms / Q000000981:diagnostic imaging* / Q000188:drug therapy* / Q000473:pathology; D002278:Carcinoma in Situ / Q000000981:diagnostic imaging* / Q000188:drug therapy* / Q000473:pathology; D018270:Carcinoma, Ductal, Breast / Q000000981:diagnostic imaging* / Q000188:drug therapy* / Q000473:pathology; D017024:Chemotherapy, Adjuvant; D005260:Female; D006801:Humans; D008327:Mammography; D008727:Methotrexate / Q000008:administration & dosage; D008875:Middle Aged; D016685:Mitomycin / Q000008:administration & dosage; D008942:Mitoxantrone / Q000008:administration & dosage; D013629:Tamoxifen / Q000008:administration & dosage
chemical_list: D000970:Antineoplastic Agents; D013629:Tamoxifen; D016685:Mitomycin; D008942:Mitoxantrone; D008727:Methotrexate